Product Information
TOBRAMYCIN 80 MG/2 ML VIAL is a generic product labeled by Baxter Healthcare Corporation, priced at $0.7395 per ML under NDC 36000024425. Its NADAC has been published 175 times since Aug 18, 2021.
FDA first approved this application on Jul 1, 2016. Its Orange Book therapeutic-equivalence code is AP.
The Low Outlier badge above means this manufacturer's average price in the Tobramycin market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
40 mg/mL
Manufacturer
Baxter Healthcare CorporationNDC
36000024425
Classification
Generic
Dosage Form
INJECTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
8/19/2026
Active Ingredients
TOBRAMYCIN SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA206965FDA Approved
7/1/2016
TE Code
AP
On Market Since
7/15/2016
Pharmacological Classes
Price Statistics
The NADAC for TOBRAMYCIN 80 MG/2 ML VIAL has been published 175 times since Aug 18, 2021, and over the history we have for it it has declined 13.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7395 per ML |
|---|---|
| All-time high | $0.9396 (Jun 12, 2024) |
| All-time low | $0.5997 (Mar 18, 2026) |
| 52-week high | $0.8372 |
| 52-week low | $0.5997 |
| Median price | $0.8144 |
| Average price | $0.8009 |
| Largest weekly change | -16.2% (Nov 20, 2024) |
| Weeks tracked | 175 |
| Tracking since | Aug 18, 2021 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TOBRAMYCIN 80 MG/2 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for TOBRAMYCIN 80 MG/2 ML VIAL, manufactured by Baxter Healthcare Corporation, is $0.7395 per ML (NDC 36000024425), effective Aug 19, 2026.
How has the price of TOBRAMYCIN 80 MG/2 ML VIAL changed over time?
Over the history we have for it, the NADAC for TOBRAMYCIN 80 MG/2 ML VIAL has declined 13.0%. It has been tracked across 175 weekly CMS publications since Aug 18, 2021.
What are the highest and lowest recorded NADAC prices for TOBRAMYCIN 80 MG/2 ML VIAL?
Since Aug 18, 2021, the NADAC for TOBRAMYCIN 80 MG/2 ML VIAL has ranged from a low of $0.5997 (Mar 18, 2026) to a high of $0.9396 (Jun 12, 2024), with a median of $0.8144 per ML.
Are there cheaper alternatives to TOBRAMYCIN 80 MG/2 ML VIAL?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TOBRAMYCIN 80 MG/2 ML VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures TOBRAMYCIN 80 MG/2 ML VIAL?
TOBRAMYCIN 80 MG/2 ML VIAL (NDC 36000024425) is labeled by Baxter Healthcare Corporation, and CMS classifies it as a generic product.